Investegate | Company Announcement
Investegate announcements from PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
Source: investegate.co.uk
📰 Pascal Birman News
Pascal Birman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pascal Birman. Real-time updates on events, politics, business and more.
PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus - PHAXIAM Therapeutics (NASDAQ:PHXM)
Approval of study design by French ANSM and Ethics Committee Recruitment of 12 patients expected to start in Q4 2023 in 4 French centersFirst study results expected in mid-2024 Lyon (France) et Cambridge (MA, US),
Source: benzinga.com
Investegate | Company Announcement
Investegate announcements from PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
France General United States Enregistrement Universel Arthur Rouill Pascal Birman Bichat Claude Bernard
Source: investegate.co.uk
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to ...
Source: marketscreener.com
Is Phage Therapy Ushering In A Post-Antibiotic Era
Faced with the emergence of resistant bacteria, phage therapy, which uses bacterial viruses (bacteriophages) to treat bacterial infections, is...
Source: pharmaceuticalonline.com
Pherecydes Pharma Organizes a Scientific Symposium During the 23rd National Days of Infectiology
Phage therapy in 2022: French experience Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE, PEA-PME eligible), a biotech company specializing in precision phage therapy to treat resistant
Pherecydes Pharma Arthur Rouill Dusan Oresansky Pascal Birman National Days Of Infectiology Bordeaux University Hospital
Source: finanznachrichten.de
Pherecydes Pharma Organizes a Scientific Symposium During the 23rd National Days of Infectiology
Phage therapy in 2022: French experiencePARIS--(BUSINESS WIRE)--Regulatory News:Pherecydes Pharma (FR0011651694 - ALPHE, PEA-PME eligible), a biotech company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces it will participate to the scientific sympo...
Arthur Rouill Pherecydes Pharma Dusan Oresansky Pascal Birman National Days Of Infectiology Bordeaux University Hospital
Source: pharmiweb.com